0001193125-24-037132.txt : 20240215 0001193125-24-037132.hdr.sgml : 20240215 20240215085459 ACCESSION NUMBER: 0001193125-24-037132 CONFORMED SUBMISSION TYPE: N-CSR PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 EFFECTIVENESS DATE: 20240215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price Equity Series, Inc. CENTRAL INDEX KEY: 0000918294 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CSR SEC ACT: 1940 Act SEC FILE NUMBER: 811-07143 FILM NUMBER: 24642324 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE EQUITY SERIES INC DATE OF NAME CHANGE: 19940131 0000918294 S000002078 T. Rowe Price All-Cap Opportunities Portfolio C000005441 T. Rowe Price All-Cap Opportunities Portfolio QAOSWX N-CSR 1 d682950dncsr.htm ALL-CAP OPPORTUNITIES PORTFOLIO_NAP_E302-050 All-Cap Opportunities Portfolio_NAP_E302-050

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act File Number: 811-07143

T. Rowe Price Equity Series, Inc.

 

(Exact name of registrant as specified in charter)

100 East Pratt Street, Baltimore, MD 21202

 

(Address of principal executive offices)

David Oestreicher

100 East Pratt Street, Baltimore, MD 21202

 

(Name and address of agent for service)

Registrant’s telephone number, including area code: (410) 345-2000

Date of fiscal year end: December 31

Date of reporting period: December 31, 2023


Item 1. Reports to Shareholders

(a) Report pursuant to Rule 30e-1

 


Annual
REPORT
December
31,
2023
All-Cap
Opportunities
Portfolio
T.
ROWE
PRICE
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
Highlights
and
Market
Commentary
Management’s
Discussion
of
Fund
Performance
Performance
and
Expenses
Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
HIGHLIGHTS
The
All-Cap
Opportunities
Portfolio
outperformed
its
benchmark,
the
Russell
3000
Index,
as
well
as
its
Lipper
peer
group
index
in
2023.
Within
the
portfolio,
favorable
stock
selection
drove
relative
outperformance.
Throughout
the
year,
we
took
a
relatively
cautious
approach,
neutralizing
factor
bets
where
possible
and
focusing
on
stock
selection
within
ideas
that
should
be
able
to
outperform
regardless
of
the
economic
backdrop.
As
a
result,
we
generated
returns
through
stock
selection,
a
byproduct
of
our
four-pillars
framework.
Stock
selection
in
industrials
and
business
services
added
value
during
the
period.
Stock
choices
in
health
care
also
boosted
relative
returns.
Conversely,
an
overweight
allocation
to
financials
pulled
down
relative
performance.
At
a
high
level,
we
continue
to
place
emphasis
on
anchoring
to
durable,
growth-at-a-reasonable-price
names,
but
we’ve
also
begun
to
slowly
lean
in
to
some
cyclical
exposure
as
the
U.S.
economic
outlook
continues
to
improve.
Log
in
to
your
account
at
troweprice.com
for
more
information.
*
An
account
service
fee
will
be
charged
annually
for
each
T.
Rowe
Price
mutual
fund
account
unless
you
meet
criteria
for
a
fee
waiver.
Go
to
troweprice.
com/personal-investing/help/fees-and-minimums.html
to
learn
more
about
this
account
service
fee,
including
other
ways
to
waive
it.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
Market
Commentary
1
Dear
Investor
Global
stock
and
bond
indexes
were
broadly
positive
during
2023
as
most
economies
managed
to
avoid
the
recession
that
was
widely
predicted
at
the
start
of
the
year.
Technology
companies
benefited
from
investor
enthusiasm
for
artificial
intelligence
developments
and
led
the
equity
rally,
while
fixed
income
benchmarks
rebounded
late
in
the
year
amid
falling
interest
rates.
For
the
12-month
period,
the
technology-oriented
Nasdaq
Composite
Index
rose
about
43%,
reaching
a
record
high
and
producing
the
strongest
result
of
the
major
benchmarks.
Growth
stocks
outperformed
value
shares,
and
developed
market
stocks
generally
outpaced
their
emerging
markets
counterparts.
Currency
movements
were
mixed
over
the
period,
although
a
weaker
dollar
versus
major
European
currencies
was
beneficial
for
U.S.
investors
in
European
securities.
Within
the
S&P
500
Index,
which
finished
the
year
just
short
of
the
record
level
it
reached
in
early
2022,
the
information
technology,
communication
services,
and
consumer
discretionary
sectors
were
all
lifted
by
the
tech
rally
and
recorded
significant
gains.
A
small
group
of
tech-oriented
mega-cap
companies
helped
drive
much
of
the
market’s
advance.
Conversely,
the
defensive
utilities
sector
had
the
weakest
returns
in
the
growth-focused
environment,
and
the
energy
sector
also
lost
ground
amid
declining
oil
prices.
The
financials
sector
bounced
back
from
the
failure
of
three
large
regional
banks
in
the
spring
and
was
one
of
the
top-
performing
segments
in
the
second
half
of
the
year.
The
U.S.
economy
was
the
strongest
among
the
major
markets
during
the
period,
with
gross
domestic
product
growth
coming
in
at
4.9%
in
the
third
quarter,
the
highest
since
the
end
of
2021.
Corporate
fundamentals
were
also
broadly
supportive.
Year-over-year
earnings
growth
contracted
in
the
first
and
second
quarters
of
2023,
but
results
were
better
than
expected,
and
earnings
growth
turned
positive
again
in
the
third
quarter.
Markets
remained
resilient
despite
a
debt
ceiling
standoff
in
the
U.S.,
the
outbreak
of
war
in
the
Middle
East,
the
continuing
conflict
between
Russia
and
Ukraine,
and
a
sluggish
economic
recovery
in
China.
Inflation
remained
a
concern,
but
investors
were
encouraged
by
the
slowing
pace
of
price
increases
as
well
as
the
possibility
that
the
Federal
Reserve
was
nearing
the
end
of
its
rate-hiking
cycle.
The
Fed
held
rates
steady
after
raising
its
short-term
lending
benchmark
rate
to
a
target
range
of
5.25%
to
5.50%
in
July,
the
highest
level
since
March
2001,
and
at
its
final
meeting
of
the
year
in
December,
the
central
bank
indicated
that
there
could
be
three
25-basis-point
rate
cuts
in
2024.
The
yield
of
the
benchmark
10-year
U.S.
Treasury
note
briefly
reached
5.00%
in
October
for
the
first
time
since
late
2007
before
falling
back
to
3.88%
by
period-end,
the
same
level
where
it
started
the
year,
amid
cooler-than-expected
inflation
readings
and
less-hawkish
Fed
rhetoric.
Fixed
income
benchmarks
were
lifted
late
in
the
year
by
falling
yields.
Investment-grade
and
high
yield
corporate
bonds
produced
solid
returns,
supported
by
the
higher
coupons
that
have
become
available
over
the
past
year,
as
well
as
increasing
hopes
that
the
economy
might
be
able
to
avoid
a
recession.
Global
economies
and
markets
showed
surprising
resilience
in
2023,
but
considerable
uncertainty
remains
as
we
look
ahead.
Geopolitical
events,
the
path
of
monetary
policy,
and
the
impact
of
the
Fed’s
rate
hikes
on
the
economy
all
raise
the
potential
for
additional
volatility.
We
believe
this
environment
makes
skilled
active
management
a
critical
tool
for
identifying
risks
and
opportunities,
and
our
investment
teams
will
continue
to
use
fundamental
research
to
help
identify
securities
that
can
add
value
to
your
portfolio
over
the
long
term.
Thank
you
for
your
continued
confidence
in
T.
Rowe
Price.
Sincerely, 
Robert
Sharps
CEO
and
President
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
Management’s
Discussion
of
Fund
Performance
2
INVESTMENT
OBJECTIVE 
The
portfolio
seeks
to
provide
long-term
capital
growth
by
investing
primarily
in
the
common
stocks
of
growth
companies.
FUND
COMMENTARY
How
did
the
fund
perform
in
the
past 12
months?
The
All-Cap
Opportunities
Portfolio
returned
28.96%
for
the
12-month
period
ended
December
31,
2023.
The
portfolio
outperformed
its
benchmark,
the
Russell
3000
Index,
and
outperformed
its
peer
group,
the
Lipper
Variable
Annuity
Underlying
Multi-Cap
Growth
Funds
Average.
(
Past
performance
cannot
guarantee
future
results.
)
What
factors
influenced
the
fund’s
performance?
Within
the
portfolio,
stock
selection
in
industrials
and
business
services
added
value.
Shares
of
General
Electric
(GE)
moved
higher
throughout
the
year
as
a
successful
spinoff
of
the
health
care
business
improved
its
balance
sheet,
and
the
company
set
promising
long-term
profitability
targets
for
its
aerospace
and
renewables
businesses.
We
like
GE
for
its
leverage
to
a
strong
multiyear
recovery
in
aviation,
underappreciated
self-help
potential
in
its
renewables
business,
and
the
potential
for
its
improved
balance
sheet
to
enhance
shareholder
value.
(Please
refer
to
the
fund’s
portfolio
of
investments
for
a
complete
list
of
our
holdings
and
the
amount
each
represents
in
the
portfolio.)
In
the
health
care
sector,
stock
selection
boosted
relative
returns,
though
our
overweight
allocation
dampened
those
gains
as
the
sector
lagged
the
benchmark
at
large.
Shares
of
Eli
Lilly
moved
higher,
thanks
to
positive
developments
for
several
late-stage
developmental
drugs
for
both
obesity
and
Alzheimer’s,
which
are
expected
to
be
major
growth
catalysts.
We
believe
Eli
Lilly
has
a
number
of
underappreciated
late-
stage
development
programs
with
high
probabilities
of
success
and
massive
commercial
opportunities.
On
an
absolute
basis,
the
portfolio’s
position
in
NVIDIA
generated
significant
positive
returns.
Shares
advanced
throughout
the
period
on
improved
visibility
around
robust
future
demand
for
advanced
graphics
processing
units
(GPUs)
that
are
critical
for
the
buildout
of
artificial
intelligence
(AI)
infrastructure.
In
our
view,
AI
applications
like
deep
learning
and
inference
will
require
a
tremendous
number
of
high-end
GPUs
to
supply
the
necessary
horsepower,
and
as
the
clear
leader
in
that
space,
NVIDIA
looks
well
positioned
to
benefit
from
increasing
demand.
NVIDIA’s
state-of-the-art
graphics
processing
units,
combined
with
its
embedded
software
intellectual
property,
have
created
an
expanding
moat
behind
which
NVIDIA
should
be
able
to
continue
to
innovate
and
grow
earnings.
Conversely,
stock
selection
in
consumer
discretionary
detracted.
Our
average
underweight
position
in
Tesla
detracted
as
shares
were
higher
through
positive
investor
sentiment
around
rivals
adopting
Tesla
charging
technology
and
the
implications
for
advancements
in
artificial
intelligence
to
improve
full
self-driving
capabilities.
We
do
not
currently
own
the
company
due
to
concerns
over
pricing
and
demand
for
electric
vehicles.
Stock
selection
and
an
overweight
allocation
in
materials
dragged
down
relative
returns
as
well.
Shares
of
Nutrien
fell
due
to
unfavorable
pricing
dynamics
combined
with
weak
demand
for
fertilizer
and
declining
U.S.
agriculture
yields.
Given
the
company’s
challenging
run
of
performance
and
the
potential
for
higher
levels
of
fertilizer
applications
in
2024,
we
believe
the
position
could
provide
an
attractive
level
of
upside
with
much
of
the
downside
already
reflected
in
the
company’s
valuation.
How
is
the
fund
positioned?
We
continue
to
seek
investment
opportunities
in
companies
that
fit
our
criteria,
the
pillars
of
which
are
high-quality
companies,
companies
trading
at
a
low
valuation,
companies
for
which
we
believe
published
numbers
are
materially
low,
and
companies
whose
fundamentals
are
on
the
cusp
of
accelerating.
At
a
high
level,
we
continue
to
place
emphasis
on
anchoring
to
durable,
growth
at
a
reasonable
price-oriented
names,
but
we’ve
also
begun
to
slowly
lean
in
to
some
cyclical
exposure
as
the
U.S.
economic
outlook
continues
to
improve.
With
the
risk
of
a
recession
largely
off
the
table,
decisions
around
positioning
become
slightly
less
complex,
allowing
us
to
focus
more
on
areas
of
the
market
that
can
outperform
in
an
environment
where
the
economy
continues
to
grow
at
a
steady
clip
or
even
heats
up
to
a
degree.
At
a
security
level,
our
largest
purchase
during
the
year
came
through
Amazon.com.
In
our
view,
the
continued
demonstration
of
efficiency
gains
within
its
logistics
network
should
help
repair
margins.
We
believe
Amazon
has
three
businesses
(e-commerce,
Amazon
Web
Services,
and
advertising)
that
are
each
levered
to
durable
secular
growth
themes,
attacking
huge
addressable
markets,
and
have
plenty
of
runway
left
for
growth.
PERFORMANCE
COMPARISON
Total
Return
Periods
Ended
12/31/23
6
Months
12
Months
All-Cap
Opportunities
Portfolio
9.38‌%
28.96‌%
Russell
3000
Index
8.43‌
25.96‌
Lipper
Variable
Annuity
Underlying
Multi-Cap
Growth
Funds
Average
7.94‌
28.56‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
3
Our
largest
purchasing
activity
on
an
absolute
basis
came
in
the
industrials
and
business
services
sector.
We
initiated
a
position
in
Uber
Technologies,
which
we
believe
has
the
potential
to
benefit
from
accelerating
bookings,
margin
expansion,
and
meaningful
free
cash
flow
generation
as
the
company
uses
its
leading
position
in
ride
share
to
expand
further
into
food
delivery.
We
also
initiated
a
position
in
Boeing,
which
we
believe
is
set
up
for
a
strong
earnings
recovery
story
as
the
company
ramps
up
production
into
an
upcycle
in
commercial
aerospace
demand.
Elsewhere
in
the
sector,
we
initiated
a
position
in
the
large
railroad
CSX,
which
we
like
for
its
margin
expansion
potential,
thanks
to
efficiency
gains.
Our
largest
sales
during
the
year
came
within
the
health
care
sector.
We
eliminated
our
position
in
Danaher,
a
manufacturer
of
life
science
tools
and
provider
of
bioprocessing
services.
While
we
believe
it’s
a
high-quality
company,
we
believe
its
industry
is
set
for
a
period
of
tempered
growth
relative
to
expectations,
and
we
rotated
funds
into
more
attractive
investment
opportunities.
We
also
made
significant
purchases
in
the
information
technology
sector,
particularly
in
the
semiconductor
industry,
where
we
initiated
positions
in
Analog
Devices,
Taiwan
Semiconductor,
and
Advanced
Micro
Devices.
We
believe
Analog
Devices
is
one
of
the
best
companies
in
its
space,
and
we
appreciate
its
differentiated
high-value
product
portfolio
in
attractive
verticals
as
well
as
its
industrial
exposures.
We’re
attracted
to
Taiwan
Semiconductor’s
leading-edge
technology
and
exposure
to
several
attractive
growth
markets.
We
believe
Advanced
Micro
Devices
is
set
to
accelerate,
with
a
new
GPU
launch
(Mi300),
giving
the
company
the
potential
to
gain
market
share
in
the
artificial
intelligence
accelerator
space.
What
is
portfolio
management’s
outlook?
We
enter
the
first
half
of
2024
with
optimism
for
prospective
equity
market
returns. The
Federal
Reserve’s
tightening
campaign
is
probably
done,
industrial
activity
is
bottoming,
and
the
labor
market
remains
robust. Animal
spirits
could
be
on
the
cusp
of
emerging
from
hibernation.
Since
World
War
II,
the
market
has
gone
up
in
100%
of
presidential
election
years
in
which
an
incumbent
was
listed
on
the
ballot,
by
roughly
14%
on
average.
The
government
apparatus
is
politically
incentivized
to
do
what
it
can
to
maintain
a
robust
economy
into
a
presidential
election.
The
biggest
risk,
in
our
view,
is
that
the
Fed
is
leaning
too
dovish
too
quickly,
which
could
cause
the
economy
to
heat
up
as
2024
goes
on. The
market
may
be
underestimating
the
potential
for
long-term
rates
to
rise
and
for
inflationary
pressure
to
reemerge. 
This
is
not
an
issue
for
the
start
of
2024,
but
it
could
become
an
issue
as
we
progress
through
the
year.
Against
this
backdrop,
we
are
trying
to
find
idiosyncratic
ideas
that
fit
our
framework. It
is
no
longer
about
growth
versus
value;
it
is
about
finding
high-quality
companies
at
reasonable
prices
where
fundamentals
are
supportive
and
earnings
risk
is
low. Our
bottom-up
framework
is
generating
a
larger
number
of
attractive
ideas
now
than
it
has
since
2021.
Specifically:
(1)
The
portfolio
remains
anchored
in
durable
growth
companies
with
reasonable
valuations
and
low
cyclicality
(Visa,
Microsoft,
Cencora,
T-Mobile
U.S.
Netflix).
(2)
We
are
leaning
in
slowly
to
cyclical
companies
that
will
benefit
from
improving
industrial
activity
and
business
confidence
(Analog
Devices,
Amphenol,
CSX).
(3)
We
remain
positive
on
energy
and
materials
on
the
view
that
supply
will
tighten
in
2024. 
We
maintain
a
moderate
overweight
position
in
these
sectors
(Schlumberger,
Seadrill,
Ero
Copper).
(4)
We
continue
to
be
underweight
profitless
tech
on
the
view
that
many
of
these
companies
remain
too
speculative
and
too
expensive.
We
continue
to
rely
on
our
fundamental
research
and
bottom-up
stock
selection
process
to
construct
your
portfolio. 
You
should
expect
the
portfolio
to
maintain
large
positions
in
many
durable
growth
companies—those
with
the
ability
to
increase
revenues
and
earnings
regardless
of
the
global
economic
environment. We
believe
that,
over
the
longer
term,
strong
risk-adjusted
returns
most
often
arise
from
owning
companies
that
are
at
the
forefront
of
innovation
and
riding
powerful,
durable
trends.
SECTOR
DIVERSIFICATION
Percent
of
Net
Assets
6/30/23
12/31/23
Information
Technology
27.2‌%
24.9‌%
Health
Care
17.7‌ 
15.9‌ 
Financials
13.3‌ 
12.3‌ 
Industrials
and
Business
Services
7.7‌ 
11.9‌ 
Communication
Services
11.2‌ 
11.7‌ 
Consumer
Discretionary
9.9‌ 
10.6‌ 
Energy
3.6‌ 
4.9‌ 
Materials
2.3‌ 
3.0‌ 
Consumer
Staples
4.8‌ 
2.4‌ 
Real
Estate
0.6‌ 
1.1‌ 
Utilities
0.0‌ 
0.0‌ 
Other
and
Reserves
1.7‌ 
1.3‌ 
Total
100.0‌%
100.0‌%
Historical
weightings
reflect
current
industry/sector
classifications.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
4
As
always,
we
will
continue
to
work
diligently
on
your
behalf.
Thank
you
for
your
continued
support
and
your
confidence
in
T.
Rowe
Price.
The
views
expressed
reflect
the
opinions
of
T.
Rowe
Price
as
of
the
date
of
this
report
and
are
subject
to
change
based
on
changes
in
market,
economic,
or
other
conditions.
These
views
are
not
intended
to
be
a
forecast
of
future
events
and
are
no
guarantee
of
future
results.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
5
RISKS
OF
STOCK
INVESTING
The
portfolio’s
share
price
can
fall
because
of
weakness
in
the
stock
markets,
a
particular
industry,
or
specific
holdings.
Stock
markets
can
decline
for
many
reasons,
including
adverse
political
or
economic
developments,
changes
in
investor
psychology,
or
heavy
institutional
selling.
The
prospects
for
an
industry
or
company
may
deteriorate
because
of
a
variety
of
factors,
including
disappointing
earnings
or
changes
in
the
competitive
environment.
In
addition,
the
investment
manager’s
assessment
of
companies
held
in
a
portfolio
may
prove
incorrect,
resulting
in
losses
or
poor
performance
even
in
rising
markets.
RISKS
OF
GROWTH
INVESTING
Growth
stocks
can
be
volatile
for
several
reasons.
Since
these
companies
usually
invest
a
high
portion
of
earnings
in
their
businesses,
they
may
lack
the
dividends
of
value
stocks
that
can
cushion
stock
prices
in
a
falling
market.
Also,
earnings
disappointments
often
lead
to
sharply
falling
prices
because
investors
buy
growth
stocks
in
anticipation
of
superior
earnings
growth.
BENCHMARK
INFORMATION
Note:
Portions
of
the
mutual
fund
information
contained
in
this
report
was
supplied
by
Lipper,
a
Refinitiv
Company,
subject
to
the
following:
Copyright
2024
©
Refinitiv.
All
rights
reserved.
Any
copying,
republication
or
redistribution
of
Lipper
content
is
expressly
prohibited
without
the
prior
written
consent
of
Lipper.
Lipper
shall
not
be
liable
for
any
errors
or
delays
in
the
content,
or
for
any
actions
taken
in
reliance
thereon.
Note:
London
Stock
Exchange
Group
plc
and
its
group
undertakings
(collectively,
the
“LSE
Group”).
©
LSE
Group
2024.
FTSE
Russell
is
a
trading
name
of
certain
of
the
LSE
Group
companies.  “Russell
®
” is/are
a
trademark(s)
of
the
relevant
LSE
Group
companies
and
is/are
used
by
any
other
LSE
Group
company
under
license.
All
rights
in
the
FTSE
Russell
indexes
or
data
vest
in
the
relevant
LSE
Group
company
which
owns
the
index
or
the
data.
Neither
LSE
Group
nor
its
licensors
accept
any
liability
for
any
errors
or
omissions
in
the
indexes
or
data
and
no
party
may
rely
on
any
indexes
or
data
contained
in
this
communication.
No
further
distribution
of
data
from
the
LSE
Group
is
permitted
without
the
relevant
LSE
Group
company’s
express
written
consent.
The
LSE
Group
does
not
promote,
sponsor
or
endorse
the
content
of
this
communication.
The
LSE
Group
is
not
responsible
for
the
formatting
or
configuration
of
this
material
or
for
any
inaccuracy
in
T.
Rowe
Price’s
presentation
thereof.
TWENTY-FIVE
LARGEST
HOLDINGS
Percent
of
Net
Assets
12/31/23
Microsoft
7.6‌%
Apple
5.5‌ 
Visa
3.3‌ 
Amazon.com
3.3‌ 
Alphabet
3.3‌ 
NVIDIA
3.0‌ 
Meta
Platforms
3.0‌ 
Eli
Lilly
2.0‌ 
T-Mobile
U.S.
1.9‌ 
Uber
Technologies
1.9‌ 
Home
Depot
1.8‌ 
UnitedHealth
Group
1.5‌ 
Roper
Technologies
1.5‌ 
Elevance
Health
1.4‌ 
Exxon
Mobil
1.4‌ 
Cencora
1.4‌ 
Coca-Cola
1.4‌ 
Marriott
International
1.3‌ 
Boeing
1.3‌ 
Netflix
1.3‌ 
Chubb
1.3‌ 
Fiserv
1.3‌ 
Linde
1.2‌ 
General
Electric
1.2‌ 
Global
Payments
1.2‌ 
Total
55.3‌%
Note:
The
information
shown
does
not
reflect
any
exchange-traded
funds
(ETFs),
cash
reserves,
or
collateral
for
securities
lending
that
may
be
held
in
the
portfolio.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
6
GROWTH
OF
$10,000 
This
chart
shows
the
value
of
a
hypothetical
$10,000
investment
in
the
portfolio
over
the
past
10
fiscal
year
periods
or
since
inception
(for portfolios
lacking
10-year
records).
The
result
is
compared
with
benchmarks,
which
include
a
broad-based
market
index
and
may
also
include
a
peer
group
average
or
index.
Market
indexes
do
not
include
expenses,
which
are
deducted
from
portfolio returns
as
well
as
mutual fund
averages
and
indexes.
ALL-CAP
OPPORTUNITIES
PORTFOLIO
AVERAGE
ANNUAL
COMPOUND
TOTAL
RETURN
FUND
EXPENSE
EXAMPLE
As
a
mutual
fund
shareholder,
you
may
incur
two
types
of
costs:
(1)
transaction
costs,
such
as
redemption
fees
or
sales
loads,
and
(2)
ongoing
costs,
including
management
fees,
distribution
and
service
(12b-
1)
fees,
and
other
fund
expenses.
The
following
example
is
intended
to
help
you
understand
your
ongoing
costs
(in
dollars)
of
investing
in
the
fund
and
to
compare
these
costs
with
the
ongoing
costs
of
investing
in
other
mutual
funds.
The
example
is
based
on
an
investment
of
$1,000
invested
at
the
beginning
of
the
most
recent
six-month
period
and
held
for
the
entire
period.
Actual
Expenses
The
first
line
of
the
following
table
(Actual)
provides
information
about
actual
account
values
and
actual
expenses.
You
may
use
the
information
on
this
line,
together
with
your
account
balance,
to
estimate
the
expenses
that
you
paid
over
the
period.
Simply
divide
your
account
value
by
$1,000
(for
example,
an
$8,600
account
value
divided
by
$1,000
=
8.6),
then
multiply
the
result
by
the
number
on
the
first
line
under
the
heading
“Expenses
Paid
During
Period”
to
estimate
the
expenses
you
paid
on
your
account
during
this
period.
Hypothetical
Example
for
Comparison
Purposes
The
information
on
the
second
line
of
the
table
(Hypothetical)
is
based
on
hypothetical
account
values
and
expenses
derived
from
the
fund’s
actual
expense
ratio
and
an
assumed
5%
per
year
rate
of
return
before
expenses
(not
the
fund’s
actual
return).
You
may
compare
the
ongoing
costs
of
investing
in
the
fund
with
other
funds
by
contrasting
this
5%
hypothetical
example
and
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
the
other
funds.
The
hypothetical
account
values
and
expenses
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period.
You
should
also
be
aware
that
the
expenses
shown
in
the
table
highlight
only
your
ongoing
costs
and
do
not
reflect
any
transaction
costs,
such
as
redemption
fees
or
sales
loads.
Therefore,
the
second
line
of
the
table
is
useful
in
comparing
ongoing
costs
only
and
will
not
help
you
determine
the
relative
total
costs
of
owning
different
funds.
To
the
extent
a
fund
charges
transaction
costs,
however,
the
total
cost
of
owning
that
fund
is
higher.
ALL-CAP
OPPORTUNITIES
PORTFOLIO
Periods
Ended
12/31/23
1
Year
5
Years
10
Years
All-Cap
Opportunities
Portfolio
28.96‌%
18.96‌%
14.57‌%
The
fund’s
performance
information
represents
only
past
performance
and
is
not
necessarily
an
indication
of
future
results.
Current
performance
may
be
lower
or
higher
than
the
performance
data
cited.
Share
price,
principal
value,
and
return
will
vary,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
For
the
most
recent
month-end
performance,
please
contact
a
T.
Rowe
Price
representative
at
1-800-469-6587
(financial
advisors,
or
customers
who
have
an
advisor,
should
call
1-800-638-8790).
Total
returns
do
not
include
charges
imposed
by
your
insurance
company’s
separate
account.
If
these
had
been
included,
performance
would
have
been
lower.
This
table
shows
how
the
portfolio
would
have
performed
each
year
if
its
actual
(or
cumulative)
returns
for
the
periods
shown
had
been
earned
at
a
constant
rate.
Average
annual
total
return
figures
include
changes
in
principal
value,
reinvested
dividends,
and
capital
gain
distributions.
When
assessing
performance,
investors
should
consider
both
short-
and
long-
term
returns.  
Beginning
Account
Value
7/1/23
Ending
Account
Value
12/31/23
Expenses
Paid
During
Period*
7/1/23
to
12/31/23
Actual
$1,000.00
$1,093.80
$4.22
Hypothetical
(assumes
5%
return
before
expenses)
 1,000.00
  1,021.17
  4.08
*
Expenses
are
equal
to
the
fund’s
annualized
expense
ratio
for
the
6-month
period
(0.80%),
multiplied
by
the
average
account
value
over
the
period,
multiplied
by
the
number
of
days
in
the
most
recent
fiscal
half
year
(184),
and
divided
by
the
days
in
the
year
(365)
to
reflect
the
half-year
period.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
Financial
Highlights
7
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
..
Year
..
..
Ended
.
12/31/23
12/31/22
12/31/21
12/31/20
12/31/19
NET
ASSET
VALUE
Beginning
of
period
$
28.66‌
$
38.68‌
$
39.66‌
$
32.28‌
$
25.69‌
Investment
activities
Net
investment
income
(loss)
(1)(2)
0.09‌
0.01‌
(0.09‌)
–‌
(3)
0.08‌
Net
realized
and
unrealized
gain/loss
8.16‌
(8.34‌)
8.03‌
14.25‌
8.86‌
Total
from
investment
activities
8.25‌
(8.33‌)
7.94‌
14.25‌
8.94‌
Distributions
Net
investment
income
(0.08‌)
–‌
–‌
–‌
(0.13‌)
Net
realized
gain
(2.43‌)
(1.69‌)
(8.92‌)
(6.87‌)
(2.22‌)
Total
distributions
(2.51‌)
(1.69‌)
(8.92‌)
(6.87‌)
(2.35‌)
NET
ASSET
VALUE
End
of
period
$
34.40‌
$
28.66‌
$
38.68‌
$
39.66‌
$
32.28‌
Ratios/Supplemental
Data
Total
return
(2)(4)
28.96‌%
(21.51‌)%
20.80‌%
44.37‌%
34.93‌%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/payments
by
Price
Associates
0.85‌%
0.85‌%
0.85‌%
0.85‌%
0.85‌%
Net
expenses
after
waivers/payments
by
Price
Associates
0.80‌%
0.80‌%
0.80‌%
0.80‌%
0.80‌%
Net
investment
income
(loss)
0.26‌%
0.03‌%
(0.20‌)%
0.01‌%
0.28‌%
Portfolio
turnover
rate
101.9‌%
104.1‌%
73.1‌%
91.6‌%
85.3‌%
Net
assets,
end
of
period
(in
thousands)
$
445,928‌
$
349,653‌
$
468,496‌
$
403,262‌
$
296,263‌
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Amounts
round
to
less
than
$0.01
per
share.
(4)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
December
31,
2023
8
Portfolio
of
Investments
Shares
$
Value
(Cost
and
value
in
$000s)
COMMON
STOCKS
97.4%
COMMUNICATION
SERVICES
11.3%
Entertainment
2.7%
Liberty
Media
Corp-Liberty
Formula
One,
Class
C  (1)
55,914‌
3,530‌
Netflix  (1)
11,626‌
5,660‌
Sea,
ADR  (1)
72,469‌
2,935‌
12,125‌
Interactive
Media
&
Services
6.7%
Alphabet,
Class
C  (1)
103,031‌
14,520‌
Meta
Platforms,
Class
A  (1)
38,064‌
13,473‌
Pinterest,
Class
A  (1)
48,795‌
1,808‌
29,801‌
Wireless
Telecommunication
Services
1.9%
T-Mobile
U.S. 
51,765‌
8,299‌
8,299‌
Total
Communication
Services
50,225‌
CONSUMER
DISCRETIONARY
10.7%
Broadline
Retail
3.3%
Amazon.com (1)
95,826‌
14,560‌
14,560‌
Hotels,
Restaurants
&
Leisure
3.8%
Cava
Group  (1)(2)
29,798‌
1,281‌
Chipotle
Mexican
Grill  (1)
1,330‌
3,042‌
Marriott
International,
Class
26,080‌
5,881‌
McDonald's 
12,200‌
3,617‌
Planet
Fitness,
Class
A  (1)
41,923‌
3,060‌
16,881‌
Leisure
Products
0.0%
Rad
Power
Bikes,
Class
A,
Acquisition
Date:
9/16/21,
Cost $885  (1)(3)(4)
92,335‌
29‌
29‌
Specialty
Retail
2.5%
AutoZone (1)
1,193‌
3,085‌
Home
Depot 
22,935‌
7,948‌
11,033‌
Textiles,
Apparel
&
Luxury
Goods
1.1%
Lululemon
Athletica  (1)
5,450‌
2,786‌
On
Holding,
Class
A  (1)
74,600‌
2,012‌
4,798‌
Total
Consumer
Discretionary
47,301‌
CONSUMER
STAPLES
2.4%
Beverages
2.4%
Celsius
Holdings  (1)
10,485‌
572‌
Coca-Cola 
102,573‌
6,045‌
PepsiCo 
23,425‌
3,978‌
Total
Consumer
Staples
10,595‌
Shares
$
Value
(Cost
and
value
in
$000s)
ENERGY
4.9%
Energy
Equipment
&
Services
2.1%
Schlumberger 
80,689‌
4,199‌
Seadrill  (1)
79,352‌
3,752‌
TechnipFMC 
63,738‌
1,284‌
9,235‌
Oil,
Gas
&
Consumable
Fuels
2.8%
Diamondback
Energy 
23,000‌
3,567‌
Exxon
Mobil 
60,800‌
6,079‌
Southwestern
Energy  (1)
437,121‌
2,863‌
12,509‌
Total
Energy
21,744‌
FINANCIALS
12.3%
Banks
1.3%
East
West
Bancorp 
31,393‌
2,259‌
JPMorgan
Chase 
20,618‌
3,507‌
5,766‌
Capital
Markets
1.2%
Charles
Schwab 
76,042‌
5,232‌
5,232‌
Financial
Services
7.7%
Apollo
Global
Management 
27,100‌
2,525‌
Fiserv  (1)
42,055‌
5,587‌
FleetCor
Technologies  (1)
8,800‌
2,487‌
Global
Payments 
41,600‌
5,283‌
Mastercard,
Class
9,200‌
3,924‌
Visa,
Class
56,705‌
14,763‌
34,569‌
Insurance
2.1%
Chubb 
24,956‌
5,640‌
Marsh
&
McLennan 
19,500‌
3,695‌
9,335‌
Total
Financials
54,902‌
HEALTH
CARE
15.2%
Biotechnology
1.2%
Argenx,
ADR  (1)
5,175‌
1,969‌
Insmed  (1)
15,900‌
493‌
Karuna
Therapeutics  (1)
7,884‌
2,495‌
Prothena  (1)
8,900‌
323‌
5,280‌
Health
Care
Equipment
&
Supplies
2.0%
Dexcom (1)
9,551‌
1,185‌
Intuitive
Surgical  (1)
12,032‌
4,059‌
Pax
Labs,
Class
A,
Acquisition
Date:
4/18/19,
Cost $484  (1)(3)(4)
128,372‌
52‌
Stryker 
12,830‌
3,842‌
9,138‌
Health
Care
Providers
&
Services
5.9%
Cencora 
29,500‌
6,059‌
Elevance
Health 
13,152‌
6,202‌
HCA
Healthcare 
8,423‌
2,280‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
9
Shares
$
Value
(Cost
and
value
in
$000s)
Molina
Healthcare  (1)
13,553‌
4,897‌
UnitedHealth
Group 
13,115‌
6,904‌
26,342‌
Health
Care
Technology
0.9%
Veeva
Systems,
Class
A  (1)
20,285‌
3,905‌
3,905‌
Life
Sciences
Tools
&
Services
1.6%
Thermo
Fisher
Scientific 
9,583‌
5,086‌
West
Pharmaceutical
Services 
6,233‌
2,195‌
7,281‌
Pharmaceuticals
3.6%
AstraZeneca,
ADR 
40,758‌
2,745‌
Eli
Lilly 
15,295‌
8,916‌
Zoetis 
23,395‌
4,617‌
16,278‌
Total
Health
Care
68,224‌
INDUSTRIALS
&
BUSINESS
SERVICES
11.8%
Aerospace
&
Defense
1.5%
Boeing (1)
22,343‌
5,824‌
Howmet
Aerospace 
16,400‌
887‌
6,711‌
Commercial
Services
&
Supplies
0.8%
Waste
Connections 
24,400‌
3,642‌
3,642‌
Electrical
Equipment
0.1%
Hubbell 
2,037‌
670‌
670‌
Ground
Transportation
3.2%
CSX 
133,100‌
4,615‌
Saia  (1)
3,342‌
1,465‌
Uber
Technologies  (1)
134,700‌
8,293‌
14,373‌
Industrial
Conglomerates
2.7%
General
Electric 
41,748‌
5,328‌
Roper
Technologies 
12,409‌
6,765‌
12,093‌
Machinery
0.5%
IDEX 
6,734‌
1,462‌
Toro 
7,412‌
711‌
2,173‌
Professional
Services
2.6%
Booz
Allen
Hamilton
Holding 
23,480‌
3,003‌
Ceridian
HCM
Holding  (1)
54,303‌
3,645‌
FTI
Consulting  (1)
23,910‌
4,762‌
11,410‌
Trading
Companies
&
Distributors
0.4%
SiteOne
Landscape
Supply  (1)
9,954‌
1,618‌
1,618‌
Total
Industrials
&
Business
Services
52,690‌
Shares
$
Value
(Cost
and
value
in
$000s)
INFORMATION
TECHNOLOGY
24.7%
Electronic
Equipment,
Instruments
&
Components
0.5%
Amphenol,
Class
20,400‌
2,022‌
2,022‌
IT
Services
0.6%
Shopify,
Class
A  (1)
34,300‌
2,672‌
2,672‌
Semiconductors
&
Semiconductor
Equipment
6.0%
Advanced
Micro
Devices  (1)
29,800‌
4,393‌
Analog
Devices 
22,500‌
4,467‌
NVIDIA 
27,406‌
13,572‌
Taiwan
Semiconductor
Manufacturing,
ADR 
43,400‌
4,514‌
26,946‌
Software
12.1%
Adobe (1)
6,300‌
3,758‌
BILL
Holdings  (1)
29,175‌
2,380‌
Canva,
Acquisition
Date:
8/16/21
-
11/4/21,
Cost $349  (1)(3)(4)
205‌
219‌
Confluent,
Class
A  (1)
58,200‌
1,362‌
Fair
Isaac  (1)
2,650‌
3,085‌
Intuit 
2,900‌
1,813‌
Microsoft 
90,205‌
33,921‌
Salesforce  (1)
17,927‌
4,717‌
Synopsys  (1)
5,364‌
2,762‌
54,017‌
Technology
Hardware,
Storage
&
Peripherals
5.5%
Apple 
128,422‌
24,725‌
24,725‌
Total
Information
Technology
110,382‌
MATERIALS
2.9%
Chemicals
2.2%
FMC 
28,800‌
1,816‌
Linde 
13,176‌
5,412‌
Nutrien 
42,916‌
2,417‌
9,645‌
Metals
&
Mining
0.7%
ERO
Copper
(CAD)  (1)
153,502‌
2,427‌
Warrior
Met
Coal 
13,300‌
811‌
3,238‌
Total
Materials
12,883‌
REAL
ESTATE
1.2%
Real
Estate
Management
&
Development
0.7%
Jones
Lang
LaSalle  (1)
15,511‌
2,930‌
2,930‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
10
Shares
$
Value
(Cost
and
value
in
$000s)
Residential
Real
Estate
Investment
Trusts
0.5%
AvalonBay
Communities,
REIT 
11,757‌
2,201‌
2,201‌
Total
Real
Estate
5,131‌
Total
Common
Stocks
(Cost
$321,800)
434,077‌
CONVERTIBLE
PREFERRED
STOCKS
0.8%
COMMUNICATION
SERVICES
0.4%
Interactive
Media
&
Services
0.4%
ByteDance,
Series
E,
Acquisition
Date:
7/8/19,
Cost $386  (1)(3)(4)
7,838‌
1,872‌
Total
Communication
Services
1,872‌
HEALTH
CARE
0.1%
Biotechnology
0.1%
Caris
Life
Sciences,
Series
D,
Acquisition
Date:
5/11/21,
Cost $292  (1)(3)(4)
36,019‌
131‌
Treeline
Biosciences,
Series
A,
Acquisition
Date:
9/26/22,
Cost $60  (1)(3)(4)
7,690‌
60‌
Total
Health
Care
191‌
INDUSTRIALS
&
BUSINESS
SERVICES
0.1%
Aerospace
&
Defense
0.1%
ABL
Space
Systems,
Series
B,
Acquisition
Date:
3/24/21,
Cost $541  (1)(3)(4)
12,016‌
421‌
ABL
Space
Systems,
Series
B-2,
Acquisition
Date:
10/22/21,
Cost $232  (1)(3)(4)
3,407‌
118‌
Total
Industrials
&
Business
Services
539‌
INFORMATION
TECHNOLOGY
0.1%
Software
0.1%
Canva,
Series
A,
Acquisition
Date:
11/4/21,
Cost $20  (1)(3)(4)
12‌
13‌
Waymo,
Series
A-2,
Acquisition
Date:
5/8/20,
Cost $747  (1)(3)(4)
8,696‌
496‌
Total
Information
Technology
509‌
Shares
$
Value
(Cost
and
value
in
$000s)
MATERIALS
0.1%
Chemicals
0.1%
Redwood
Materials,
Series
C,
Acquisition
Date:
5/28/21,
Cost $441  (1)(3)(4)
9,305‌
444‌
Total
Materials
444‌
Total
Convertible
Preferred
Stocks
(Cost
$2,719)
3,555‌
PREFERRED
STOCKS
0.5%
HEALTH
CARE
0.5%
Life
Sciences
Tools
&
Services
0.5%
Sartorius
(EUR) 
6,519‌
2,394‌
Total
Health
Care
2,394‌
Total
Preferred
Stocks
(Cost
$2,465)
2,394‌
SHORT-TERM
INVESTMENTS
1.5%
Money
Market
Funds
1.5%
T.
Rowe
Price
Government
Reserve
Fund,
5.42%  (5)(6)
6,654,198‌
6,654‌
Total
Short-Term
Investments
(Cost
$6,654)
6,654‌
SECURITIES
LENDING
COLLATERAL
0.0%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
STATE
STREET
BANK
AND
TRUST
COMPANY
0.0%
Money
Market
Funds
0.0%
T.
Rowe
Price
Government
Reserve
Fund,
5.42%  (5)(6)
55,907‌
56‌
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
State
Street
Bank
and
Trust
Company
56‌
Total
Securities
Lending
Collateral
(Cost
$56)
56‌
Total
Investments
in
Securities
100.2%
of
Net
Assets
(Cost
$333,694)
$
446,736‌
Shares
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
(1)
Non-income
producing
(2)
See
Note
3
.
All
or
a
portion
of
this
security
is
on
loan
at
December
31,
2023.
(3)
See
Note
2.
Level
3
in
fair
value
hierarchy.
(4)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
may
have
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
generally
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$3,855
and
represents
0.9%
of
net
assets.
(5)
Seven-day
yield
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
11
.
(6)
Affiliated
Companies
ADR
American
Depositary
Receipts
CAD
Canadian
Dollar
EUR
Euro
REIT
A
domestic
Real
Estate
Investment
Trust
whose
distributions
pass-through
with
original
tax
character
to
the
shareholder
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
12
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
year
ended
December
31,
2023.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
5.42%
$
—‌
$
—‌
$
291‌++
Totals
$
—‌#
$
—‌
$
291‌+
Supplementary
Investment
Schedule
Affiliate
Value
12/31/22
Purchase
Cost
Sales
Cost
Value
12/31/23
T.
Rowe
Price
Government
Reserve
Fund,
5.42%
$
12,579‌
 ¤
  ¤
$
6,710‌
Total
$
6,710‌^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees
as
described
in
Note
3
.
+
Investment
income
comprised
$291
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$6,710.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
December
31,
2023
Statement
of
Assets
and
Liabilities
13
($000s,
except
shares
and
per
share
amounts)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Assets
Investments
in
securities,
at
value
(cost
$333,694)
$
446,736‌
Receivable
for
investment
securities
sold
1,414‌
Receivable
for
shares
sold
383‌
Dividends
receivable
164‌
Foreign
currency
(cost
$1)
1‌
Other
assets
31‌
Total
assets
448,729‌
Liabilities
Payable
for
investment
securities
purchased
2,156‌
Investment
management
and
administrative
fees
payable
319‌
Payable
for
shares
redeemed
270‌
Obligation
to
return
securities
lending
collateral
56‌
Total
liabilities
2,801‌
NET
ASSETS
$
445,928‌
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
120,397‌
Paid-in
capital
applicable
to
12,961,910
shares
of
$0.0001
par
value
capital
stock
outstanding;
1,000,000,000
shares
of
the
Corporation
authorized
325,531‌
NET
ASSETS
$
445,928‌
NET
ASSET
VALUE
PER
SHARE
$
34.40‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
Statement
of
Operations
14
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
0
Year
Ended
12/31/23
Investment
Income
(Loss)
Income
Dividend
(net
of
foreign
taxes
of
$41)
$
4,128‌
Securities
lending
47‌
Total
income
4,175‌
Expenses
Investment
management
and
administrative
expense
3,344‌
Waived
/
paid
by
Price
Associates
(196‌)
Net
expenses
3,148‌
Net
investment
income
1,027‌
Realized
and
Unrealized
Gain
/
Loss  
Net
realized
gain
on
securities
38,621‌
Change
in
net
unrealized
gain
/
loss
Securities
60,655‌
Other
assets
and
liabilities
denominated
in
foreign
currencies
2‌
Change
in
net
unrealized
gain
/
loss
60,657‌
Net
realized
and
unrealized
gain
/
loss
99,278‌
INCREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
100,305‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
Statement
of
Changes
in
Net
Assets
15
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Year
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ended
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
12/31/23
12/31/22
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
income
$
1,027‌
$
113‌
Net
realized
gain
38,621‌
9,157‌
Change
in
net
unrealized
gain
/
loss
60,657‌
(108,578‌)
Increase
(decrease)
in
net
assets
from
operations
100,305‌
(99,308‌)
Distributions
to
shareholders
Net
earnings
(30,327‌)
(19,375‌)
Capital
share
transactions
*
Shares
sold
51,805‌
43,018‌
Distributions
reinvested
30,327‌
19,375‌
Shares
redeemed
(55,835‌)
(62,553‌)
Increase
(decrease)
in
net
assets
from
capital
share
transactions
26,297‌
(160‌)
Net
Assets
Increase
(decrease)
during
period
96,275‌
(118,843‌)
Beginning
of
period
349,653‌
468,496‌
End
of
period
$
445,928‌
$
349,653‌
*Share
information
(000s)
Shares
sold
1,607‌
1,331‌
Distributions
reinvested
897‌
681‌
Shares
redeemed
(1,741‌)
(1,924‌)
Increase
in
shares
outstanding
763‌
88‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
16
NOTES
TO
FINANCIAL
STATEMENTS
T.
Rowe
Price
Equity
Series,
Inc.
(the
corporation) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act).
The
All-
Cap
Opportunities
Portfolio
(the
fund)
is a
diversified, open-end
management
investment
company
established
by
the
corporation. The
fund
seeks
to
provide
long-term
capital
growth
by
investing
primarily
in
the
common
stocks
of
growth
companies.
Shares
of
the
fund are
currently offered
only
to
insurance
company
separate
accounts
established
for
the
purpose
of
funding
variable
annuity
contracts
and
variable
life
insurance
policies.
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES 
Basis
of
Preparation
 The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
Investment
Transactions,
Investment
Income,
and
Distributions
 Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis. Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense. Dividends
received
from other
investment
companies are
reflected
as
dividend
income;
capital
gain
distributions
are
reflected
as
realized
gain/loss. Dividend
income and
capital
gain
distributions
are
recorded
on
the
ex-dividend
date. Distributions
from
REITs
are
initially
recorded
as
dividend
income
and,
to
the
extent
such
represent
a
return
of
capital
or
capital
gain
for
tax
purposes,
are
reclassified
when
such
information
becomes
available. Non-cash
dividends,
if
any,
are
recorded
at
the
fair
market
value
of
the
asset
received. Proceeds
from
litigation
payments,
if
any,
are
included
in
either
net
realized
gain
(loss)
or
change
in
net
unrealized
gain/loss
from
securities. Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date. Income
distributions,
if
any,
are
declared
and
paid annually. A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
Currency
Translation
 Assets,
including
investments,
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Purchases
and
sales
of
securities,
income,
and
expenses
are
translated
into
U.S.
dollars
at
the
prevailing
exchange
rate
on
the
respective
date
of
such
transaction.
The
effect
of
changes
in
foreign
currency
exchange
rates
on
realized
and
unrealized
security
gains
and
losses
is
not
bifurcated
from
the
portion
attributable
to
changes
in
market
prices.
Capital
Transactions
 Each
investor’s
interest
in
the
net
assets
of the
fund
is
represented
by
fund
shares. The
fund’s
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
New
Accounting
Guidance
 In
June
2022,
the
FASB
issued
Accounting
Standards
Update
(ASU),
ASU
2022-03,
Fair
Value
Measurement
(Topic
820)
Fair
Value
Measurement
of
Equity
Securities
Subject
to
Contractual
Sale
Restrictions,
which
clarifies
that
a
contractual
restriction
on
the
sale
of
an
equity
security
is
not
considered
part
of
the
unit
of
account
of
the
equity
security
and,
therefore,
is
not
considered
in
measuring
fair
value.
The
amendments
under
this
ASU
are
effective
for
fiscal
years
beginning
after
December
15,
2023;
however,
the
fund
opted
to
early
adopt,
as
permitted,
effective
December
1,
2022. Adoption
of
the
guidance
did not
have
a
material
impact
on
the fund's
financial  statements.
Indemnification
 In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund’s
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
17
NOTE
2
-
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
the fund’s portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Assets
and
liabilities
other
than
financial
instruments,
including
short-term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value. 
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
18
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
December
31,
2023
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
NOTE
3
-
OTHER
INVESTMENT
TRANSACTIONS 
Consistent
with
its
investment
objective,
the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of
the
fund
are
described
more
fully
in
the
fund's
prospectus
and
Statement
of
Additional
Information.
Restricted
Securities
 The
fund
invests
in
securities
that
are
subject
to
legal
or
contractual
restrictions
on
resale.
Prompt
sale
of
such
securities
at
an
acceptable
price
may
be
difficult
and
may
involve
substantial
delays
and
additional
costs.
Securities
Lending
 The fund
may
lend
its
securities
to
approved
borrowers
to
earn
additional
income.
Its
securities
lending
activities
are
administered
by
a
lending
agent
in
accordance
with
a
securities
lending
agreement.
Security
loans
generally
do
not
have
stated
maturity
dates,
and
the
fund
may
recall
a
security
at
any
time.
The
fund
receives
collateral
in
the
form
of
cash
or
U.S.
government
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
the
value
of
loaned
securities;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
fund
the
next
business
day.
Cash
collateral
is
invested
in
accordance
with
investment
guidelines
approved
by
fund
management.
Additionally,
the
lending
agent
indemnifies
the
fund
against
losses
resulting
from
borrower
default.
Although
risk
is
mitigated
by
the
collateral
and
indemnification,
the
fund
could
experience
a
delay
in
recovering
its
securities
and
a
possible
loss
of
income
or
value
if
the
borrower
fails
to
return
the
securities,
collateral
investments
decline
in
value,
and
the
lending
agent
fails
to
perform.
Securities
lending
revenue
consists
of
earnings
on
invested
collateral
and
borrowing
fees,
net
of
any
rebates
to
the
borrower,
compensation
to
the
lending
agent,
and
other
administrative
costs.
In
accordance
with
GAAP,
investments
made
with
cash
collateral
are
reflected
in
the
accompanying
financial
statements,
but
collateral
received
in
the
form
of
securities
is
not.
At
December
31,
2023,
the
value
of
loaned
securities
was
$53,000;
the
value
of
cash
collateral
and
related
investments
was
$56,000.
Other 
Purchases
and
sales
of
portfolio
securities
other
than
in-kind
transactions,
if
any,
and short-term securities
aggregated $398,031,000 and
$394,463,000,
respectively,
for
the
year ended
December
31,
2023.
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
431,350‌
$
2,427‌
$
300‌
$
434,077‌
Convertible
Preferred
Stocks
—‌
—‌
3,555‌
3,555‌
Preferred
Stocks
—‌
2,394‌
—‌
2,394‌
Short-Term
Investments
6,654‌
—‌
—‌
6,654‌
Securities
Lending
Collateral
56‌
—‌
—‌
56‌
Total
$
438,060‌
$
4,821‌
$
3,855‌
$
446,736‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
19
NOTE
4
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its taxable
income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
The
fund
files
U.S.
federal,
state,
and
local
tax
returns
as
required.
The
fund’s
tax
returns
are
subject
to
examination
by
the
relevant
tax
authorities
until
expiration
of
the
applicable
statute
of
limitations,
which
is
generally
three
years
after
the
filing
of
the
tax
return
but
which
can
be
extended
to
six
years
in
certain
circumstances.
Tax
returns
for
open
years
have
incorporated
no
uncertain
tax
positions
that
require
a
provision
for
income
taxes.
Capital
accounts
within
the
financial
reporting
records
are
adjusted
for
permanent
book/tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
permanent
book/tax
adjustments,
if
any,
have
no
impact
on
results
of
operations
or
net
assets.
The
tax
character
of
distributions
paid
for
the
periods
presented
was
as
follows:
At
December
31,
2023,
the
tax-basis
cost
of
investments
(including
derivatives,
if
any)
and
gross
unrealized
appreciation
and
depreciation
were as
follows:
At
December
31,
2023,
the
tax-basis
components
of
accumulated
net
earnings
(loss)
were
as
follows:
Temporary
differences
between
book-basis
and
tax-basis
components
of
total
distributable
earnings
(loss)
arise
when
certain
items
of
income,
gain,
or
loss
are
recognized
in
different
periods
for
financial
statement
purposes
versus
for
tax
purposes;
these
differences
will
reverse
in
a
subsequent
reporting
period.
The
temporary
differences
relate
primarily
to
the
deferral
of
losses
from
wash
sales.
NOTE
5
-
FOREIGN  TAXES
The
fund
is
subject
to
foreign
income
taxes
imposed
by
certain
countries
in
which
it
invests.
Additionally,
capital
gains
realized
upon
disposition
of
securities
issued
in
or
by
certain
foreign
countries
are
subject
to
capital
gains
tax
imposed
by
those
countries.
All
taxes
are
computed
in
accordance
with
the
applicable
foreign
tax
law,
and,
to
the
extent
permitted,
capital
losses
are
used
to
offset
capital
gains.
Taxes
attributable
to
income
are
accrued
by
the
fund
as
a
reduction
of
income.
Current
and
deferred
tax
expense
attributable
to
capital
($000s)
December
31,
2023
December
31,
2022
Ordinary
income
(including
short-term
capital
gains,
if
any)
$
14,155‌
$
241‌
Long-term
capital
gain
16,172‌
19,134‌
Total
distributions
$
30,327‌
$
19,375‌
($000s)
Cost
of
investments
$
334,657‌
Unrealized
appreciation
$
118,835‌
Unrealized
depreciation
(6,756‌)
Net
unrealized
appreciation
(depreciation)
$
112,079‌
($000s)
Undistributed
ordinary
income
$
3,128‌
Undistributed
long-term
capital
gain
5,190‌
Net
unrealized
appreciation
(depreciation)
112,079‌
Total
distributable
earnings
(loss)
$
120,397‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
20
gains
is
reflected
as
a
component
of
realized
or
change
in
unrealized
gain/loss
on
securities
in
the
accompanying
financial
statements.
To
the
extent
that
the
fund
has
country
specific
capital
loss
carryforwards,
such
carryforwards
are
applied
against
net
unrealized
gains
when
determining
the
deferred
tax
liability.
Any
deferred
tax
liability
incurred
by
the
fund
is
included
in
either
Other
liabilities
or
Deferred
tax
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
NOTE
6
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group). The
investment
management
and
administrative
agreement
between
the
fund
and
Price
Associates
provides
for
an
all-
inclusive
annual
fee
equal
to
0.85%
of
the
fund’s
average
daily
net
assets.
The
fee
is
computed
daily
and
paid
monthly. The
all-inclusive
fee
covers
investment
management
services
and
ordinary,
recurring
operating
expenses
but
does
not
cover
interest
expense;
expenses
related
to
borrowing,
taxes,
and
brokerage;
or
nonrecurring,
extraordinary
expenses. Effective
July
1,
2018,
Price
Associates
has
contractually
agreed,
at
least
through
April
30,
2024
to
waive
a
portion
of
its
management
fee
in
order
to
limit
the
fund’s
management
fee
to
0.80%
of
the
fund’s
average
daily
net
assets.
Thereafter,
this
agreement
automatically
renews
for
one-year
terms
unless
terminated
or
modified
by
the
fund’s
Board.
Fees
waived
and
expenses
paid
under
this
agreement
are
not
subject
to
reimbursement
to
Price
Associates
by
the
fund. The
total
management
fees
waived
were $196,000
for
the
year
ended
December
31,
2023.
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
a
wholly
owned
subsidiary
of
Price
Associates,
each
an
affiliate
of
the
fund.
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
funds.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund’s
transfer
and
dividend-disbursing
agent.
Pursuant
to
the
all-inclusive
fee
arrangement
under
the
investment
management
and
administrative
agreement,
expenses
incurred
by
the
funds
pursuant
to
these
service
agreements
are
paid
by
Price
Associates.
T.
Rowe
Price
Investment
Services,
Inc.
(Investment
Services)
serves
as
distributor
to
the
fund.
Pursuant
to
an
underwriting
agreement,
no
compensation
for
any
distribution
services
provided
is
paid
to
Investment
Services
by
the
fund
(except
for
12b-1
fees
under
a
Board-
approved
Rule
12b-1
plan).
The fund
may
invest
its
cash
reserves
in
certain
open-end
management
investment
companies
managed
by
Price
Associates
and
considered
affiliates
of
the
fund:
the
T.
Rowe
Price
Government
Reserve
Fund
or
the
T.
Rowe
Price
Treasury
Reserve
Fund,
organized
as
money
market
funds
(together,
the
Price
Reserve
Funds).
The
Price
Reserve
Funds
are
offered
as
short-term
investment
options
to
mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
and
are
not
available
for
direct
purchase
by
members
of
the
public.
Cash
collateral
from
securities
lending,
if
any,
is
invested
in
the
T.
Rowe
Price
Government
Reserve Fund. The
Price
Reserve
Funds
pay
no
investment
management
fees.
The
fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund’s
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
independent
current
market
price
of
the
security.
During
the
year
ended
December
31,
2023,
the
fund
had
no
purchases
or
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates.
Price
Associates
has
voluntarily
agreed
to
reimburse
the
fund
from
its
own
resources
on
a
monthly
basis
for
the
cost
of
investment
research
embedded
in
the
cost
of
the
fund’s
securities
trades.
This
agreement
may
be
rescinded
at
any
time.
For
the
year ended
December
31,
2023,
this
reimbursement
amounted
to
$15,000,
which
is
included
in
Net
realized
gain
(loss)
on
Securities
in
the
Statement
of
Operations.
NOTE
7
-
OTHER
MATTERS
Unpredictable
events
such
as
environmental
or
natural
disasters,
war
and
conflict,
terrorism,
geopolitical
events,
and
public
health
epidemics and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-
existing
political,
social,
and
economic
risks.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
21
The
global
outbreak
of
COVID-19
and
the
related
governmental
and
public
responses
have
led
and
may
continue
to
lead
to
increased
market
volatility
and
the
potential
for
illiquidity
in
certain
classes
of
securities
and
sectors
of
the
market
either
in
specific
countries
or
worldwide.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict,
leading
to
economic
sanctions imposed
on
Russia
that
target certain
of
its
citizens
and
issuers
and
sectors
of
the
Russian
economy,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
In
March
2023,
the
banking
industry
experienced
heightened
volatility,
which
sparked
concerns
of
potential
broader
adverse
market
conditions.
The
extent
of
impact
of
these
events
on
the
US
and
global
markets
is
highly
uncertain.
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund’s
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
NOTE
8
-
SUBSEQUENT
EVENT 
At
a
meeting
held
on
October
23,
2023,
the
Board
approved
an
amendment
to
the
fund’s
investment
management
agreement
to
change
the
fund’s
all-inclusive
fee
structure
to
one
where
the
management
fee
covers
only
investment
management
and
other
specified
services,
but
operating
expenses
(including
payments
for
administrative
services)
are
borne
by
the
fund,
effective
May
1,
2024.
In
addition,
effective
May
1,
2024,
the
Board
approved
implementing
an
indefinite
contractual
total
expense
limitation
at
the
level
of
the
fund’s
current
all-inclusive
fee
rate
(including
any
management
fee
waivers),
excluding
interest,
taxes,
brokerage
and
other
transaction
costs,
and
nonrecurring
and
extraordinary
expenses
(expenses
currently
excluded
from
the
fund’s
all-inclusive
fee
rate).
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
22
Report
of
Independent
Registered
Public
Accounting
Firm
To
the
Board
of
Directors
of
T.
Rowe
Price
Equity
Series,
Inc.
and
Shareholders
of
T.
Rowe
Price
All-Cap
Opportunities
Portfolio
Opinion
on
the
Financial
Statements
We
have
audited
the
accompanying
statement
of
assets
and
liabilities,
including
the
portfolio
of
investments,
of
T.
Rowe
Price
All-Cap
Opportunities
Portfolio
(one
of
the
portfolios
constituting
T.
Rowe
Price
Equity
Series,
Inc.,
referred
to
hereafter
as
the
"Fund")
as
of
December
31,
2023,
the
related
statement
of
operations
for
the
year
ended
December
31,
2023,
the
statement
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
December
31,
2023,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
December
31,
2023
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
the
Fund
as
of
December
31,
2023,
the
results
of
its
operations
for
the
year
then
ended,
the
changes
in
its
net
assets
for
each
of
the
two
years
in
the
period
ended
December
31,
2023
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
December
31,
2023
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinion
These
financial
statements
are
the
responsibility
of
the
Fund’s
management.
Our
responsibility
is
to
express
an
opinion
on
the
Fund’s
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Fund
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
December
31,
2023
by
correspondence
with
the
custodians,
transfer
agent
and
brokers;
when
replies
were
not
received
from
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinion.
/s/
PricewaterhouseCoopers
LLP
Baltimore,
Maryland
February
12,
2024
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
T.
Rowe
Price
group
of
investment
companies
since
1973.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
23
TAX
INFORMATION
(UNAUDITED)
FOR
THE
TAX
YEAR
ENDED 12/31/23
We
are
providing
this
information
as
required
by
the
Internal
Revenue
Code.
The
amounts
shown
may
differ
from
those
elsewhere
in
this
report
because
of
differences
between
tax
and
financial
reporting
requirements.
The
fund’s
distributions
to
shareholders
included:
$13,135,000 from
short-term
capital
gains 
$16,172,000 from
long-term
capital
gains,
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%
For
taxable
non-corporate
shareholders,
$3,527,000 of
the
fund's
income
represents
qualified
dividend
income
subject
to
a
long-term
capital
gains
tax
rate
of
not
greater
than
20%.
For
corporate
shareholders,
$2,908,000
of
the
fund's
income
qualifies
for
the
dividends-received
deduction.  
For
individuals
and
certain
trusts
and
estates
which
are
entitled
to
claim
a
deduction
of
up
to
20%
of
their
combined
qualified
real
estate
investment
trust
(REIT)
dividends,
$56,000 of
the
fund's
income
qualifies
as
qualified
real
estate
investment
trust
(REIT)
dividends.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
24
INFORMATION
ON
PROXY
VOTING
POLICIES,
PROCEDURES,
AND
RECORDS
A
description
of
the
policies
and
procedures
used
by
T.
Rowe
Price
funds
to
determine
how
to
vote
proxies
relating
to
portfolio
securities
is
available
in
each
fund’s
Statement
of
Additional
Information.
You
may
request
this
document
by
calling
1-800-225-5132
or
by
accessing
the
SEC’s
website,
sec.gov.
The
description
of
our
proxy
voting
policies
and
procedures
is
also
available
on
our
corporate
website.
To
access
it,
please
visit
the
following
Web
page:
https://www.troweprice.com/corporate/us/en/utility/policies.html
Scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Guidelines.”
Click
on
the
links
in
the
shaded
box.
Each
fund’s
most
recent
annual
proxy
voting
record
is
available
on
our
website
and
through
the
SEC’s
website.
To
access
it
through
T.
Rowe
Price,
visit
the
website
location
shown
above,
and
scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Records.”
Click
on
the
Proxy
Voting
Records
link
in
the
shaded
box.
HOW
TO
OBTAIN
QUARTERLY
PORTFOLIO
HOLDINGS
The
fund
files
a
complete
schedule
of
portfolio
holdings
with
the
Securities
and
Exchange
Commission
(SEC)
for
the
first
and
third
quarters
of
each
fiscal
year
as
an
exhibit
to
its
reports
on
Form
N-PORT.
The
fund’s
reports
on
Form
N-PORT
are
available
electronically
on
the
SEC’s
website
(sec.gov).
In
addition,
most
T.
Rowe
Price
funds
disclose
their
first
and
third
fiscal
quarter-end
holdings
on
troweprice.com
.
TAILORED
SHAREHOLDER
REPORTS
FOR
MUTUAL
FUNDS
AND
EXCHANGE
TRADED
FUNDS
In
October
2022,
the
Securities
and
Exchange
Commission
(SEC)
adopted
rule
and
form
amendments
requiring
Mutual
Funds
and
Exchange-Traded
Funds
to
transmit
concise
and
visually
engaging
streamlined
annual
and
semiannual
reports
that
highlight
key
information
to
shareholders.
Other
information,
including
financial
statements,
will
no
longer
appear
in
the
funds’
shareholder
reports
but
will
be
available
online,
delivered
free
of
charge
upon
request,
and
filed
on
a
semiannual
basis
on
Form
N-CSR.
The
rule
and
form
amendments
have
a
compliance
date
of
July
24,
2024.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
25
LIQUIDITY
RISK
MANAGEMENT
PROGRAM
In
accordance
with
Rule
22e-4
(Liquidity
Rule)
under
the
Investment
Company
Act
of
1940,
as
amended,
the
fund
has
established
a
liquidity
risk
management
program
(Liquidity
Program)
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk,
which
generally
represents
the
risk
that
the
fund
would
not
be
able
to
meet
redemption
requests
without
significant
dilution
of
remaining
investors’
interests
in
the
fund.
The
fund’s
Board
of
Directors
(Board)
has
appointed
the
fund’s
investment
adviser,
T.
Rowe
Price
Associates,
Inc.
(Adviser),
as
the
administrator
of
the
Liquidity
Program.
As
administrator,
the
Adviser
is
responsible
for
overseeing
the
day-to-day
operations
of
the
Liquidity
Program
and,
among
other
things,
is
responsible
for
assessing,
managing,
and
reviewing
with
the
Board
at
least
annually
the
liquidity
risk
of
each
T.
Rowe
Price
fund.
The
Adviser
has
delegated
oversight
of
the
Liquidity
Program
to
a
Liquidity
Risk
Committee
(LRC),
which
is
a
cross-
functional
committee
composed
of
personnel
from
multiple
departments
within
the
Adviser.
The Liquidity
Program’s
principal
objectives
include
supporting
the
T.
Rowe
Price
funds’
compliance
with
limits
on
investments
in
illiquid
assets
and
mitigating
the
risk
that
the
fund
will
be
unable
to
timely
meet
its
redemption
obligations.
The
Liquidity
Program
also
includes
a
number
of
elements
that
support
the
management
and
assessment
of
liquidity
risk,
including
an
annual
assessment
of
factors
that
influence
the
fund’s
liquidity
and
the
periodic
classification
and
reclassification
of
a
fund’s
investments
into
categories
that
reflect
the
LRC’s
assessment
of
their
relative
liquidity
under
current
market
conditions.
Under
the
Liquidity
Program,
every
investment
held
by
the
fund
is
classified
at
least
monthly
into
one
of
four
liquidity
categories
based
on
estimations
of
the
investment’s
ability
to
be
sold
during
designated
time
frames
in
current
market
conditions
without
significantly
changing
the
investment’s
market
value.
As
required
by
the
Liquidity
Rule,
at
a
meeting
held
on
July
24,
2023,
the
Board
was
presented
with
an
annual
assessment
that
was
prepared
by
the
LRC
on
behalf
of
the
Adviser
and
addressed
the
operation
of
the
Liquidity
Program
and
assessed
its
adequacy
and
effectiveness
of
implementation,
including
any
material
changes
to
the
Liquidity
Program
and
the
determination
of
each
fund’s
Highly
Liquid
Investment
Minimum
(HLIM).
The
annual
assessment
included
consideration
of
the
following
factors,
as
applicable:
the
fund’s
investment
strategy
and
liquidity
of
portfolio
investments
during
normal
and
reasonably
foreseeable
stressed
conditions,
including
whether
the
investment
strategy
is
appropriate
for
an
open-end
fund,
the
extent
to
which
the
strategy
involves
a
relatively
concentrated
portfolio
or
large
positions
in
particular
issuers,
and
the
use
of
borrowings
for
investment
purposes
and
derivatives;
short-term
and
long-term
cash
flow
projections
covering
both
normal
and
reasonably
foreseeable
stressed
conditions;
and
holdings
of
cash
and
cash
equivalents,
as
well
as
available
borrowing
arrangements.
For the
fund
and
other
T.
Rowe
Price
funds,
the
annual
assessment
incorporated
a
report
related
to
a
fund’s
holdings,
shareholder
and
portfolio
concentration,
any
borrowings
during
the
period,
cash
flow
projections,
and
other
relevant
data
for
the
period
of
April
1,
2022,
through
March
31,
2023.
The
report
described
the
methodology
for
classifying
a
fund’s
investments
(including
any
derivative
transactions)
into
one
of
four
liquidity
categories,
as
well
as
the
percentage
of
a
fund’s
investments
assigned
to
each
category.
It
also
explained
the
methodology
for
establishing
a
fund’s
HLIM
and
noted
that
the
LRC
reviews
the
HLIM
assigned
to
each
fund
no
less
frequently
than
annually.
During the
period
covered
by
the
annual
assessment,
the
LRC
has
concluded,
and
reported
to
the
Board,
that
the
Liquidity
Program
continues
to
operate
adequately
and
effectively
and
is
reasonably
designed
to
assess
and
manage
the
fund’s
liquidity
risk.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
26
ABOUT
THE
PORTFOLIO'S
DIRECTORS
AND
OFFICERS
Your
fund
is
overseen
by
a
Board
of
Directors
(Board)
that
meets
regularly
to
review
a
wide
variety
of
matters
affecting
or
potentially
affecting
the
fund,
including
performance,
investment
programs,
compliance
matters,
advisory
fees
and
expenses,
service
providers,
and
business
and
regulatory
affairs.
The
Board
elects
the
fund’s
officers,
who
are
listed
in
the
final
table.
The
directors
who
are
also
employees
or
officers
of
T.
Rowe
Price
are
considered
to
be
“interested”
directors
as
defined
in
Section
2(a)(19)
of
the
1940
Act
because
of
their
relationships
with
T.
Rowe
Price
Associates,
Inc.
(T.
Rowe
Price), and
its
affiliates.
The
business
address
of
each
director
and
officer
is
100
East
Pratt
Street,
Baltimore,
Maryland
21202.
The
Statement
of
Additional
Information
includes
additional
information
about
the
fund
directors
and
is
available
without
charge
by
calling
a
T.
Rowe
Price
representative
at
1-800-638-5660.
INDEPENDENT
DIRECTORS
(a)
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
Teresa
Bryce
Bazemore
(1959)
2018
[209]
President
and
Chief
Executive
Officer,
Federal
Home
Loan
Bank
of
San
Francisco
(2021
to
present);
Chief
Executive
Officer,
Bazemore
Consulting
LLC
(2018
to
2021);
Director,
Chimera
Investment
Corporation
(2017
to
2021);
Director,
First
Industrial
Realty
Trust
(2020
to
present);
Director,
Federal
Home
Loan
Bank
of
Pittsburgh
(2017
to
2019)
Melody
Bianchetto
(1966)
2023
[209]
Vice
President
for
Finance,
University
of
Virginia
(2015
to
2023)
Bruce
W.
Duncan
(1951)
2013
[209]
President,
Chief
Executive
Officer,
and
Director,
CyrusOne,
Inc.
(2020
to
2021);
Chair
of
the
Board
(2016
to
2020)
and
President
(2009
to
2016),
First
Industrial
Realty
Trust,
owner
and
operator
of
industrial
properties;
Member,
Investment
Company
Institute
Board
of
Governors
(2017
to
2019);
Member,
Independent
Directors
Council
Governing
Board
(2017
to
2019);
Senior
Advisor,
KKR
(2018
to
2022);
Director,
Boston
Properties
(2016
to
present);
Director,
Marriott
International,
Inc.
(2016
to
2020)
Robert
J.
Gerrard,
Jr.
(1952)
2012
[209]
Chair
of
the
Board,
all
funds
(July
2018
to
present)
Paul
F.
McBride
(1956)
2013
[209]
Advisory
Board
Member,
Vizzia
Technologies
(2015
to
present);
Board
Member,
Dunbar
Armored
(2012
to
2018)
Mark
J.
Parrell
(1966)
2023
[209]
Board
of
Trustees
Member
and
Chief
Executive
Officer
(2019
to
present),
President
(2018
to
present),
Executive
Vice
President
and
Chief
Financial
Officer
(2007
to
2018),
and
Senior
Vice
President
and
Treasurer
(2005
to
2007),
EQR;
Member,
Nareit
Dividends
Through
Diversity,
Equity
&
Inclusion
CEO
Council
and
Chair,
Nareit
2021
Audit
and
Investment
Committee
(2021);
Advisory
Board,
Ross
Business
School
at
University
of
Michigan
(2015
to
2016);
Member,
National
Multifamily
Housing
Council
and
served
as
Chair
of
the
Finance
Committee
(2015
to
2016);
Member,
Economic
Club
of
Chicago;
Director,
Brookdale
Senior
Living,
Inc.
(2015
to
2017);
Director,
Aviv
REIT,
Inc.
(2013
to
2015);
Director,
Real
Estate
Roundtable
and
the
2022
Executive
Board
Nareit;
Board
of
Directors
and
Chair
of
the
Finance
Committee,
Greater
Chicago
Food
Depository
Kellye
L.
Walker
(1966)
2021
[209]
Executive
Vice
President
and
Chief
Legal
Officer,
Eastman
Chemical
Company
(April
2020
to
present);
Executive
Vice
President
and
Chief
Legal
Officer,
Huntington
Ingalls
Industries,
Inc.
(January
2015
to
March
2020);
Director,
Lincoln
Electric
Company
(October
2020
to
present)
(a)
All
information
about
the
independent
directors
was
current
as
of
December
31,
2022,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
27
INTERESTED  DIRECTORS
(a)
OFFICERS
Name
(Year
of
Birth)
Year
Elected
[Number
of
T.
Rowe
Price
Portfolios
Overseen]
Principal
Occupation(s)
and
Directorships
of
Public
Companies
and
Other
Investment
Companies
During
the
Past
Five
Years
David
Oestreicher
(1967)
2018
[209]
Director,
Vice
President,
and
Secretary,
T.
Rowe
Price,
T.
Rowe
Price
Investment
Services,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
and
T.
Rowe
Price
Services,
Inc.;
Director
and
Secretary,
T.
Rowe
Price
Investment
Management,
Inc.
(Price
Investment
Management);
Vice
President
and
Secretary,
T.
Rowe
Price
International
(Price
International);
Vice
President,
T.
Rowe
Price
Hong
Kong
(Price
Hong
Kong),
T.
Rowe
Price
Japan
(Price
Japan),
and
T.
Rowe
Price
Singapore
(Price
Singapore);
General
Counsel,
Vice
President,
and
Secretary,
T.
Rowe
Price
Group,
Inc.;
Chair
of
the
Board,
Chief
Executive
Officer,
President,
and
Secretary,
T.
Rowe
Price
Trust
Company;
Principal
Executive
Officer
and
Executive
Vice
President,
all
funds
Eric
L.
Veiel,
CFA
(1972)
2022
[209]
Director
and
Vice
President,
T.
Rowe
Price;
Vice
President,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company;
Vice
President,
Global
Funds
(a)
All
information
about
the
interested
directors
was
current
as
of
December
31,
2022,
unless
otherwise
indicated,
except
for
the
number
of
portfolios
overseen,
which
is
current
as
of
the
date
of
this
report.
Name
(Year
of
Birth)
Position
Held
With Equity
Series 
Principal
Occupation(s) 
Ziad
Bakri,
M.D.,
CFA
(1980)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Brian
W.H.
Berghuis,
CFA
(1958)
Executive
Vice
President
Vice
President,
Price
Investment
Management,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Armando
(Dino)
Capasso
(1974)
Chief
Compliance
Officer
and
Vice
President
Chief
Compliance
Officer
and
Vice
President,
T.
Rowe
Price
and
Price
Investment
Management;
Vice
President,
T.
Rowe
Price
Group,
Inc.;
formerly,
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
AST
Investment
Services,
Inc.
(ASTIS)
(to
2022);
Chief
Compliance
Officer,
PGIM
Retail
Funds
complex
and
Prudential
Insurance
Funds
(to
2022);
Vice
President
and
Deputy
Chief
Compliance
Officer,
PGIM
Investments
LLC
and
ASTIS
(to
2019)
Jean-Marc
Corredor
(1976)
Vice
President
Vice
President,
T.
Rowe
Price, T.
Rowe
Price
Group,
Inc.,
Price
International,
Price
Investment
Management, T.
Rowe
Price
Services,
Inc., and
T.
Rowe
Price
Trust
Company
Alan
S.
Dupski,
CPA
(1982)
Principal
Financial
Officer,
Vice
President,
and
Treasurer
Vice
President,
Price
Investment
Management,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Cheryl
Emory
(1963)
Assistant
Secretary 
Assistant
Vice
President
and
Assistant
Secretary,
T.
Rowe
Price;
Assistant
Secretary,
T.
Rowe
Price
Group,
Inc.,
Price
Investment
Management,
Price
International,
Price
Hong
Kong,
Price
Singapore,
T.
Rowe
Price
Investment
Services,
Inc.,
T.
Rowe
Price
Retirement
Plan
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Paul
D.
Greene
II
(1978)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Cheryl
Hampton,
CPA
(1969)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company;
formerly,
Tax
Director,
Invesco
Ltd.
(to
2021);
Vice
President,
Oppenheimer
Funds,
Inc.
(to
2019)
Stephon
Jackson,
CFA
(1962)
Co-president 
Director
and
President,
Price
Investment
Management;
Vice
President,
T.
Rowe
Price
Group,
Inc.
Benjamin
Kersse,
CPA
(1989)
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Trust
Company
Paul
J.
Krug,
CPA
(1964)
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
John
D.
Linehan,
CFA
(1965)
Executive
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
28
Name
(Year
of
Birth)
Position
Held
With Equity
Series 
Principal
Occupation(s) 
Robert
P.
McDavid
(1972)
Vice
President
Vice
President,
T.
Rowe
Price, Price
Investment
Management, T.
Rowe
Price
Investment
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Joshua
Nelson
(1977)
Co-president 
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
Price
International,
and
T.
Rowe
Price
Trust
Company
Fran
M.
Pollack-Matz
(1961)
Vice
President
and
Secretary 
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
T.
Rowe
Price
Investment
Services,
Inc., T.
Rowe
Price
Services,
Inc.,
and
T.
Rowe
Price
Trust
Company
Richard
Sennett,
CPA
(1970)
Assistant
Treasurer
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
and
T.
Rowe
Price
Trust
Company
Charles
M.
Shriver,
CFA
(1967)
Executive
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
Price
International,
and
T.
Rowe
Price
Trust
Company
Neil
Smith
(1972)
Executive
Vice
President
Vice
President,
Price
Hong
Kong,
Price
Japan,
Price
Singapore,
T.
Rowe
Price
Group,
Inc.,
and
Price
International
Toby
M.
Thompson,
CAIA,
CFA
(1971)
Executive
Vice
President
Vice
President,
T.
Rowe
Price,
T.
Rowe
Price
Group,
Inc.,
Price
International,
and
T.
Rowe
Price
Trust
Company
John
F.
Wakeman
(1962)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Group,
Inc.
Justin
P.
White  (1981)
Executive
Vice
President
Vice
President,
T.
Rowe
Price
and
T.
Rowe
Price
Group,
Inc.
Ellen
York
(1988)
Vice
President
Vice
President,
Price
Investment
Management
and
T.
Rowe
Price
Unless
otherwise
noted,
officers
have
been
employees
of
T.
Rowe
Price
or
Price
International
for
at
least
5
years.
OFFICERS
(CONTINUED)
100
East
Pratt
Street
Baltimore,
MD
21202
T.
Rowe
Price
Investment
Services,
Inc.
Call
1-800-225-5132
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
202402-3282389
E302-050
2/24


Item 1. (b) Notice pursuant to Rule 30e-3.

Not applicable.

Item 2. Code of Ethics.

The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.

Item 3. Audit Committee Financial Expert.

The registrant’s Board of Directors has determined that Mr. Paul F. McBride qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR. Mr. McBride is considered independent for purposes of Item 3 of Form N-CSR.

Item 4. Principal Accountant Fees and Services.

(a) – (d)  Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant’s principal accountant were as follows:

 

    

2023

      

2022

      

Audit Fees

   $ 24,714        $ 21,734  

Audit-Related Fees

     -          -  

Tax Fees

     -          -  

All Other Fees

     -          -  

Audit fees include amounts related to the audit of the registrant’s annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant’s financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant’s pro-rata share of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant’s Board of Directors/Trustees.

(e)(1)  The registrant’s audit committee has adopted a policy whereby audit and non-audit services performed by the registrant’s principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approval in advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approval may be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approval for audit or non-audit services requiring fees of a de minimis amount is not permitted.

  (2)  No services included in (b) – (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

 


(f)  Less than 50 percent of the hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.

(g)  The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant’s principal accountant for non-audit services rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $1,524,000 and $2,037,000, respectively.

(h)  All non-audit services rendered in (g) above were pre-approved by the registrant’s audit committee. Accordingly, these services were considered by the registrant’s audit committee in maintaining the principal accountant’s independence.

Item 5. Audit Committee of Listed Registrants.

Not applicable.

Item 6. Investments.

(a)  Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.

(b)  Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10. Submission of Matters to a Vote of Security Holders.

There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.

Item 11. Controls and Procedures.

(a)  The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.

(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 


Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 13. Exhibits.

 

(a)(1)  The registrant’s code of ethics pursuant to Item 2 of Form N-CSR is attached.

(2)  Separate certifications by the registrant’s principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.

(3)  Written solicitation to repurchase securities issued by closed-end companies: not applicable.

(b) A certification by the registrant’s principal executive officer and principal financial officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

T. Rowe Price Equity Series, Inc.
By  

/s/ David Oestreicher

     
  David Oestreicher  
  Principal Executive Officer  
Date    February 12, 2024  

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By  

/s/ David Oestreicher

     
  David Oestreicher  
  Principal Executive Officer  
Date   

February 12, 2024

 

 

By  

/s/ Alan S. Dupski

     
  Alan S. Dupski  
  Principal Financial Officer  
Date   

February 12, 2024

 
 
EX-99.CERT 2 d682950dex99cert.htm 302 CERTIFICATIONS 302 CERTIFICATIONS

Item 13. (a)(2)

CERTIFICATIONS

I, David Oestreicher, certify that:

 

1.

I have reviewed this report on Form N-CSR of T. Rowe Price All-Cap Opportunities Portfolio;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 12, 2024      

/s/ David Oestreicher

      David Oestreicher
      Principal Executive Officer


CERTIFICATIONS

I, Alan S. Dupski, certify that:

 

1.

I have reviewed this report on Form N-CSR of T. Rowe Price All-Cap Opportunities Portfolio;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 12, 2024      

/s/ Alan S. Dupski

      Alan S. Dupski
      Principal Financial Officer
EX-99.906CE 3 d682950dex99906ce.htm 906 CERTIFICATIONS 906 CERTIFICATIONS

Item 13. (b)

CERTIFICATION UNDER SECTION 906 OF SARBANES-OXLEY ACT OF 2002

Name of Issuer: T. Rowe Price All-Cap Opportunities Portfolio

In connection with the Report on Form N-CSR for the above named Issuer, the undersigned hereby certifies, to the best of his knowledge, that:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;

 

  2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

 

Date: February 12, 2024

     

/s/ David Oestreicher

      David Oestreicher
      Principal Executive Officer

Date: February 12, 2024

     

/s/ Alan S. Dupski

      Alan S. Dupski
      Principal Financial Officer
EX-99.CODE ETH 4 d682950dex99codeeth.htm CODE OF ETHICS CODE OF ETHICS

CODE OF ETHICS FOR PRINCIPAL EXECUTIVE AND SENIOR FINANCIAL

OFFICERS OF THE T. ROWE PRICE MUTUAL FUNDS AND EXCHANGE-

TRADED FUNDS

UNDER THE SARBANES-OXLEY ACT OF 2002

I. General Statement. This Code of Ethics for the T. Rowe Price Mutual Funds and Exchange-Traded Funds (the “Price ETFs” and, together with the Mutual Funds, the “Price Funds”) has been designed to bring the Price Funds into compliance with the applicable requirements of the Sarbanes-Oxley Act of 2002 (the “Act”) and rules promulgated by the Securities and Exchange Commission thereunder (“Regulations”). This Price Funds’ Code of Ethics (the “S-O Code”) applies solely to the Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer or Controller of, or persons performing similar functions for, a Price Fund (whether such persons are employed by a Price Fund or third party) (“Covered Officers”). The “Price Funds” shall include each mutual fund and ETF that is managed, sponsored and distributed by affiliates of T. Rowe Price Group, Inc. (“Group”). The investment managers to the Price Funds will be referred to as the “Price Fund Advisers.” A list of Covered Officers is attached as Exhibit A.

The Price Fund Advisers have, along with their parent, T. Rowe Price Group, Inc. (“Group”) also maintained a comprehensive Code of Ethics and Conduct (the “Group Code”) since 1972, which applies to all officers, directors and employees of the Price Funds, Group and its affiliates.

As mandated by the Act, Group has adopted a Code (the “Group S-O Code”), similar to the Price Funds S-O Code, which applies solely to its principal executive and senior financial officers. The Group S-O Code and the Price Funds S-O Code will be referred to collectively as the “S-O Codes”.

The Price Funds S-O Code has been adopted by the Price Funds in accordance with the Act and Regulations thereunder and will be administered in conformity with the disclosure requirements of Item 2 of Form N-CSR. The S-O Codes are attachments to the Group Code. In many respects the S-O Codes are supplementary to the Group Code, but the Group Code is administered separately from the S-O Codes, as the S-O Codes are from each other.

II. Purpose of the Price Funds S-O Code. The purpose of the Price Funds S-O Code, as mandated by the Act and the Regulations, is to establish standards that are reasonably designed to deter wrongdoing and to promote:

Ethical Conduct. Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships.

Disclosure. Full, fair, accurate, timely and understandable disclosure in reports and documents that the Price Funds file with, or submit to, the SEC and in other public communications made by the Price Funds.

Compliance. Compliance with applicable governmental laws, rules and regulations.

Reporting of Violations. The prompt internal reporting of violations of the Price Funds S-O Code to an appropriate person or persons identified in the Price Funds S-O Code.

Accountability. Accountability for adherence to the Price Funds S-O Code.

 

1


III. Covered Officers Should Handle Ethically Actual and Apparent Conflicts of Interest.

Overview. Each Covered Officer owes a duty to the Price Funds to adhere to a high standard of honesty and business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.

A “conflict of interest” occurs when a Covered Officer’s private interest interferes with the interests of, or his or her service to, the Price Funds. For example, a conflict of interest would arise if a Covered Officer, or a member of his or her family, receives improper personal benefits as a result of his or her position with a Price Fund.

Certain conflicts of interest covered by the Price Funds S-O Code arise out of the relationships between Covered Officers and the Price Funds and may already be subject to provisions regulating conflicts of interest in the Investment Company Act of 1940 (“Investment Company Act”), the Investment Advisers Act of 1940 (“Investment Advisers Act”) and the Group Code. For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with a Price Fund because of their status as “affiliated persons” of a Price Fund. The compliance programs and procedures of the Price Funds and Price Fund Advisers are designed to prevent, or identify and correct, violations of these provisions.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between a Price Fund and its Price Fund Adviser (and its affiliates) of which the Covered Officers may also be officers or employees. As a result, the Price Funds S-O Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Price Funds or for the Price Fund Advisers, or for both), be involved in establishing policies and implementing decisions which will have different effects on these entities. The participation of the Covered Officers in such activities is inherent in the contractual relationship between each Price Fund and its respective Price Fund Adviser. Such participation is also consistent with the performance by the Covered Officers of their duties as officers of the Price Funds and, if consistent with the provisions of the Investment Company Act and the Investment Advisers Act, it will be deemed to have been handled ethically.

Other conflicts of interest are covered by the Price Funds and Price ETFs S-O Code, even if these conflicts of interest are not addressed by or subject to provisions in the Investment Company Act and the Investment Advisers Act.

Whenever a Covered Officer is confronted with a conflict of interest situation where he or she is uncertain as to the appropriate action to be taken, he or she should discuss the matter with the Chairperson of Group’s Ethics Committee or another member of the Committee.

Handling of Specific Types of Conflicts. Each Covered Officer (and close family members) must not:

Entertainment. Accept entertainment from any company with which any Price Fund or any Price Fund Adviser has current or prospective business dealings including portfolio companies, unless such entertainment is in full compliance with the policy on entertainment as set forth in the Group Code.

 

2


Gifts. Accept any gifts, except as permitted by the Group Code.

Improper Personal Influence. Use his or her personal influence or personal relationships improperly to influence investment decisions, brokerage allocations or financial reporting by the Price Funds to the detriment of any one or more of the Price Funds.

Taking Action at the Expense of a Price Fund. Cause a Price Fund to take action, or fail to take action, for the personal benefit of the Covered Officer rather than for the benefit of one or more of the Price Funds.

Misuse of Price Funds’ Transaction Information. Use knowledge of portfolio transactions made or contemplated for a Price Fund or any other clients of the Price Fund Advisers to trade personally or cause others to trade in order to take advantage of or avoid the market impact of such portfolio transactions; and in connection with Price ETFs that do not disclose portfolio holdings daily, use knowledge of pending changes to an ETF’s proxy portfolio holdings for such purposes.

Outside Business Activities. Engage in any outside business activity that detracts from a Covered Officer’s ability to devote appropriate time and attention to his or her responsibilities to a Price Fund.

Service Providers. Excluding Group and its affiliates, have any ownership interest in, or any consulting or employment relationship with, any of the Price Funds’ service providers, except that an ownership interest in public companies is permitted

Receipt of Payments. Have a direct or indirect financial interest in commissions, transaction charges, spreads or other payments paid by a Price Fund for effecting portfolio transactions or for selling or redeeming shares other than an interest (such as compensation or equity ownership) arising from the Covered Officer’s employment by Group or any of its affiliates.

Service as a Director or Trustee. Serve as a director, trustee or officer of any public or private company or a non-profit organization that issues securities eligible for purchase by any of the Price Funds, unless approval is obtained as required by the Group Code.

IV. Covered Officers’ Specific Obligations and Accountabilities.

A. Disclosure Requirements and Controls. Each Covered Officer must familiarize himself or herself with the disclosure requirements (Form N-lA registration statement, proxy (Schedule 14A), shareholder reports, Forms N-CEN, N-CSR, etc.) applicable to the Price Funds and the disclosure controls and procedures of the Price Fund and the Price Fund Advisers.

B. Compliance with Applicable Law. It is the responsibility of each Covered Officer to promote compliance with all laws, rules and regulations applicable to the Price Funds and the Price Fund Advisers. Each Covered Officer should, to the extent appropriate within his or her area of responsibility, consult with other officers and employees of the Price Funds and the Price Fund Advisers and take other appropriate steps with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Price Funds file with, or submit to, the SEC, and in other public

 

3


communications made by the Price Funds.

C.  Fair Disclosure. Each Covered Officer must not knowingly misrepresent, or cause others to misrepresent, facts about a Price Fund to others, whether within or outside the Price organization, including to the Price Fund’s directors and auditors, and to governmental regulators and self-regulatory organizations.

D. Initial and Annual Affirmations. Each Covered Officer must:

1. Upon adoption of the Price Funds S-O Code (or thereafter, as applicable, upon becoming a Covered Officer), affirm in writing that he or she has received, read, and understands the Price Funds S-O Code.

2. Annually affirm that he or she has complied with the requirements of the Price Funds S-O Code.

E. Reporting of Material Violations of the Price Funds S-O Code. If a Covered Officer becomes aware of any material violation of the Price Funds S-O Code or laws and governmental rules and regulations applicable to the operations of the Price Funds, he or she must promptly report the violation (“Report”) to the Chief Compliance Officer of the Price Funds (“CCO”). Failure to report a material violation will be considered itself a violation of the Price Funds S-O Code. The CCO is identified in the attached Exhibit B.

It is the Price Funds’ policy that no retaliation or other adverse action will be taken against any Covered Officer or other employee of a Price Fund, a Price Fund Adviser or their affiliates based upon any lawful actions of the Covered Officer or employee with respect to a Report made in good faith.

F. Annual Disclosures. Each Covered Officer must report, at least annually, all affiliations or other relationships as called for in the “Annual Compliance Certification” for T. Rowe Price Group.

V. Administration of the Price Funds S-O Code. The Ethics Committee is responsible for administering the Price Funds S-O Code and applying its provisions to specific situations in which questions are presented.

A. Waivers and Interpretations. The Chairperson of the Ethics Committee has the authority to interpret the Price Funds S-O Code in any particular situation and to grant waivers where justified, subject to the approval of the Joint Audit Committee of the Price Funds. All material interpretations concerning Covered Officers will be reported to the Joint Audit Committee of the Price Funds at its next meeting. Waivers, including implicit waivers, to Covered Officers will be publicly disclosed as required in the Instructions to N-CSR. Pursuant to the definition in the Regulations, an implicit waiver means a Price Fund’s failure to take action within a reasonable period of time regarding a material departure from a provision of the Price Funds S-O Code that has been made known to an “executive officer” (as defined in Rule 3b-7 under the Securities Exchange Act of 1934) of a Price Fund. An executive officer of a Price Fund includes its president and any vice-president in charge of a principal business unit, division or function.

B. Violations/Investigations. The following procedures will be followed in

 

4


investigating and enforcing the Price Funds S-O Code:

1. The CCO will take or cause to be taken appropriate action to investigate any potential or actual violation reported to him or her.

2. The CCO, after consultation if deemed appropriate with Outside Counsel to the Price Funds, will make a recommendation to the appropriate Price Funds Board regarding the action to be taken with regard to each material violation. Such action could include any of the following: a letter of censure or suspension, a fine, a suspension of trading privileges or termination of officership or employment. In addition, the violator may be required to surrender any profit realized (or loss avoided) from any activity that is in violation of the Price Funds S-O Code.

3. Investigations of Whistleblower complaints related to Price Funds will be handled in accordance with the T. Rowe Price Global Whistleblower Policy.

VI. Amendments to the Price Funds S-O Code. Except as to the contents of Exhibit A and Exhibit B, the Price Funds S-O Code may not be materially amended except in written form, which is specifically approved or ratified by a majority vote of each Price Fund Board, including a majority of the independent directors on each Board.

VII. Confidentiality. All reports and records prepared or maintained pursuant to the Price Funds S-O Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law, the Price Funds S-O Code or as necessary in connection with regulations under the Price Funds S-O Code, such matters shall not be disclosed to anyone other than the directors of the appropriate Price Fund Board, Outside Counsel to the Price Funds, members of the Ethics Committee and the CCO and authorized persons on his or her staff.

Adoption Date: 10/22/03

Last Revised:   05/11/2022 (Exhibit B revised)

 

5


Exhibit A

Persons Covered by the Price Funds and

Price ETFs S-O Code of Ethics

David Oestreicher, Executive Vice President and Principal Executive Officer

Alan S. Dupski, Treasurer and Principal Financial Officer

Exhibit B

Dino Capasso, Chief Compliance Officer

 

6